V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
J
JNJAI Stock Diagnostic Report

J&J’s Tremfya shows maintained fistula remission in Crohn’s trial

Positive clinical results indicating that Tremfya demonstrates a maintenance effect on Crohn's disease fistula closure are a positive factor for the stock price.

View Source Article ↗
AI CATALYST SCORE68 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

JNJ Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-10-25 21:56:56JNJ68MidView Report →
2026-10-19 12:13:11JNJ68MidView Report →
2026-10-13 20:49:41JNJ82MidView Report →
View Full History for JNJ (Blueprint) →